Literature DB >> 25732156

Awareness of breast density and its impact on breast cancer detection and risk.

Deborah J Rhodes1, Carmen Radecki Breitkopf2, Jeanette Y Ziegenfuss2, Sarah M Jenkins2, Celine M Vachon2.   

Abstract

PURPOSE: Legislation mandating disclosure of breast density (BD) information has passed in 21 states; however, actual awareness of BD and knowledge of its impact on breast cancer detection and risk are unknown.
METHODS: We conducted a national cross-sectional survey administered in English and Spanish using a probability-based sample of screening-age women, with oversampling of Connecticut, the only state with BD legislation in effect for > 1 year before the survey.
RESULTS: Of 2,311 women surveyed, 65% responded. Overall, 58% of women had heard of BD, 49% knew that BD affects breast cancer detection, and 53% knew that BD affects cancer risk. After multivariable adjustment, increased BD awareness was associated with white non-Hispanic race/ethnicity (Hispanic v white non-Hispanic: odds ratio [OR], 0.23; P < .001), household income (OR, 1.07 per category increase; P < .001), education (OR, 1.19 per category increase; P < .001), diagnostic evaluation after a mammogram (OR, 2.64; P < .001), and postmenopausal hormone therapy (OR, 1.69; P = .002). Knowledge of the masking effect of BD was associated with higher household income (OR, 1.10; P < .001), education (OR, 1.22; P = .01), prior breast biopsy (OR, 2.16; P < .001), and residing in Connecticut (Connecticut v other states: OR, 3.82; P = .003). Connecticut residents were also more likely to have discussed their BD with a health care provider (67% v 43% for residents of other US states; P = .001).
CONCLUSION: Disparities in BD awareness and knowledge exist by race/ethnicity, education, and income. BD legislation seems to be effective in increasing knowledge of BD impact on breast cancer detection. These findings support continued and targeted efforts to improve BD awareness and knowledge among women eligible for screening mammography.
© 2015 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2015        PMID: 25732156      PMCID: PMC4551864          DOI: 10.1200/JCO.2014.57.0325

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  29 in total

1.  Postmenopausal hormone therapy and change in mammographic density.

Authors:  Gail A Greendale; Beth A Reboussin; Stacey Slone; Carol Wasilauskas; Malcolm C Pike; Giske Ursin
Journal:  J Natl Cancer Inst       Date:  2003-01-01       Impact factor: 13.506

2.  Case-control study of factors associated with failure to detect breast cancer by mammography.

Authors:  L Ma; E Fishell; B Wright; W Hanna; S Allan; N F Boyd
Journal:  J Natl Cancer Inst       Date:  1992-05-20       Impact factor: 13.506

3.  Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.

Authors:  R Ballard-Barbash; S H Taplin; B C Yankaskas; V L Ernster; R D Rosenberg; P A Carney; W E Barlow; B M Geller; K Kerlikowske; B K Edwards; C F Lynch; N Urban; C A Chrvala; C R Key; S P Poplack; J K Worden; L G Kessler
Journal:  AJR Am J Roentgenol       Date:  1997-10       Impact factor: 3.959

4.  Case-control study of increased mammographic breast density response to hormone replacement therapy.

Authors:  Celine M Vachon; Thomas A Sellers; Robert A Vierkant; Fang-Fang Wu; Kathleen R Brandt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-11       Impact factor: 4.254

5.  Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.

Authors:  M T Mandelson; N Oestreicher; P L Porter; D White; C A Finder; S H Taplin; E White
Journal:  J Natl Cancer Inst       Date:  2000-07-05       Impact factor: 13.506

6.  Analysis of parenchymal density on mammograms in 1353 women 25-79 years old.

Authors:  P C Stomper; D J D'Souza; P A DiNitto; M A Arredondo
Journal:  AJR Am J Roentgenol       Date:  1996-11       Impact factor: 3.959

7.  Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy.

Authors:  C M Rutter; M T Mandelson; M B Laya; D J Seger; S Taplin
Journal:  JAMA       Date:  2001-01-10       Impact factor: 56.272

8.  Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage.

Authors:  P C Stomper; R B Penetrante; S B Edge; M A Arredondo; L E Blumenson; C C Stewart
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.

Authors:  Patricia A Carney; Diana L Miglioretti; Bonnie C Yankaskas; Karla Kerlikowske; Robert Rosenberg; Carolyn M Rutter; Berta M Geller; Linn A Abraham; Steven H Taplin; Mark Dignan; Gary Cutter; Rachel Ballard-Barbash
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

10.  Factors contributing to mammography failure in women aged 40-49 years.

Authors:  Diana S M Buist; Peggy L Porter; Constance Lehman; Stephen H Taplin; Emily White
Journal:  J Natl Cancer Inst       Date:  2004-10-06       Impact factor: 13.506

View more
  48 in total

1.  Prevalence and correlates of nicotine and nicotine product perceptions in U.S. young adults, 2016.

Authors:  Andrea C Villanti; Shelly Naud; Julia C West; Jennifer L Pearson; Olivia A Wackowski; Raymond S Niaura; Elizabeth Hair; Jessica M Rath
Journal:  Addict Behav       Date:  2019-06-10       Impact factor: 3.913

2.  Identifying "social smoking" U.S. young adults using an empirically-driven approach.

Authors:  Andrea C Villanti; Amanda L Johnson; Jessica M Rath; Valerie Williams; Donna M Vallone; David B Abrams; Donald Hedeker; Robin J Mermelstein
Journal:  Addict Behav       Date:  2017-02-10       Impact factor: 3.913

Review 3.  Breast Density Knowledge and Awareness: A Review of Literature.

Authors:  Marimer Santiago-Rivas; Shayna Benjamin; Lina Jandorf
Journal:  J Prim Care Community Health       Date:  2016-02-23

4.  Breast Density Legislation and the Promise Not Attained.

Authors:  Jennifer S Haas
Journal:  J Gen Intern Med       Date:  2019-02       Impact factor: 5.128

5.  "You probably can't feel as safe as normal women": Hispanic women's reactions to breast density notification.

Authors:  Alsacia L Pacsi-Sepulveda; Rachel C Shelton; Carmen B Rodriguez; Arielle T Coq; Parisa Tehranifar
Journal:  Cancer       Date:  2019-02-15       Impact factor: 6.860

6.  Breast Density Awareness and Knowledge, and Intentions for Breast Cancer Screening in a Diverse Sample of Women Age Eligible for Mammography.

Authors:  Marimer Santiago-Rivas; Shayna Benjamin; Janna Z Andrews; Lina Jandorf
Journal:  J Cancer Educ       Date:  2019-02       Impact factor: 2.037

7.  Prospective associations between nicotine beliefs and tobacco-related susceptibility, curiosity, and use in U.S. adults.

Authors:  Andrea C Villanti; Shelly Naud; Julia C West; Jennifer L Pearson; Olivia A Wackowski; Elizabeth Hair; Raymond S Niaura; Jessica M Rath
Journal:  Prev Med       Date:  2020-10-15       Impact factor: 4.018

8.  Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography.

Authors:  Susan H Busch; Jessica R Hoag; Jenerius A Aminawung; Xiao Xu; Ilana B Richman; Pamela R Soulos; Kelly A Kyanko; Cary P Gross
Journal:  Am J Public Health       Date:  2019-03-21       Impact factor: 9.308

9.  Randomized Trial of Personalized Breast Density and Breast Cancer Risk Notification.

Authors:  Jennifer S Haas; Catherine S Giess; Kimberly A Harris; Julia Ansolabehere; Celia P Kaplan
Journal:  J Gen Intern Med       Date:  2018-08-08       Impact factor: 5.128

10.  A Qualitative Study of Spanish-Speakers' Experience with Dense Breast Notifications in a Massachusetts Safety-Net Hospital.

Authors:  Christine M Gunn; Amy Fitzpatrick; Sarah Waugh; Michelle Carrera; Nancy R Kressin; Michael K Paasche-Orlow; Tracy A Battaglia
Journal:  J Gen Intern Med       Date:  2018-10-22       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.